BridgeBio Pharma (BBIO) PT Raised to $89 at Raymond James

February 12, 2026 10:03 AM EST Send to a Friend
Raymond James analyst Martin Auster raised the price target on BridgeBio Pharma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login